Back

Achievements with NOACs in NVAF to date

3 September 2019 (13:00 - 13:10)
Organised by:
Congress Presentation Part of: Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) Atrial Fibrillation (AF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Martine Gilard

Hospital Cavale Blanche, Brest (France)

4 More presentations in this session

Presentation thumbnail
NOACs in atrial fibrillation: Current landscape in clinical practice
Professor N. Danchin (Paris, FR)
Slides Video
Presentation thumbnail
Exploring evidence for long-standing questions
Professor R. Lopes (Durham, US)
Slides Video
Presentation thumbnail
Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?
Professor P. Sinnaeve (Leuven, BE)
Slides Video
Presentation thumbnail
Questions and answers
Professor M. Gilard (Brest, FR) Professor R. Lopes (Durham, US)
Slides

Access the full session

Session thumbnail
Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

The Event

Event poster

ESC Congress 2019

3 September 2019 13:00 CET
You may be interested in
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022
thumbnail
Congress Presentation
Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study
2 September 2019
thumbnail
Congress Presentation
NOACs preserve cognitive performance in hypertensive patients with atrial fibrillation
29 June 2021
thumbnail
Congress Presentation
What do real-world analyses tell us about NOACs?
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources